Cargando…

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

Cancer cells with heterogeneous mutation landscapes and extensive functional redundancy easily develop resistance to monotherapies by emerging activation of compensating or bypassing pathways. To achieve more effective and sustained clinical responses, synergistic interactions of multiple druggable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jing, Gautam, Prson, Gupta, Abhishekh, He, Liye, Timonen, Sanna, Akimov, Yevhen, Wang, Wenyu, Szwajda, Agnieszka, Jaiswal, Alok, Turei, Denes, Yadav, Bhagwan, Kankainen, Matti, Saarela, Jani, Saez-Rodriguez, Julio, Wennerberg, Krister, Aittokallio, Tero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614366/ https://www.ncbi.nlm.nih.gov/pubmed/31312514 http://dx.doi.org/10.1038/s41540-019-0098-z

Ejemplares similares

Improved detection of differentially represented DNA barcodes for high‐throughput clonal phenomics
por: Akimov, Yevhen, et al.
Publicado: (2020)

Multi‐modal meta‐analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor
por: Jaiswal, Alok, et al.
Publicado: (2021)

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening
por: Gupta, Abhishekh, et al.
Publicado: (2020)

Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
por: Gautam, Prson, et al.
Publicado: (2016)

Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells
por: Jaiswal, Alok, et al.
Publicado: (2017)

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
por: Tang, Jing, et al.
Publicado: (2013)

From drug response profiling to target addiction scoring in cancer cell models
por: Yadav, Bhagwan, et al.
Publicado: (2015)

Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
por: Yadav, Bhagwan, et al.
Publicado: (2015)

Corrigendum to “Searching for drug synergy in complex dose–response landscapes using an interaction potency model” [Comput. Struct. Biotechnol. J. 13 (2015) 504–513]
por: Yadav, Bhagwan, et al.
Publicado: (2017)

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
por: He, Liye, et al.
Publicado: (2015)

Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors
por: Cichonska, Anna, et al.
Publicado: (2017)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening
por: Potdar, Swapnil, et al.
Publicado: (2020)

What is synergy? The Saariselkä agreement revisited
por: Tang, Jing, et al.
Publicado: (2015)

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data
por: Mpindi, John-Patrick, et al.
Publicado: (2015)

P1228: GENOME-WIDE CRISPR-CAS9 SCREENING IDENTIFIES THERAPEUTIC TARGETS FOR MATURE T-CELL MALIGNANCIES
por: Timonen, Sanna, et al.
Publicado: (2023)

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
por: Potdar, Swapnil, et al.
Publicado: (2023)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)

Drug Target Commons 2.0: a community platform for systematic analysis of drug–target interaction profiles
por: Tanoli, ZiaurRehman, et al.
Publicado: (2018)

Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach
por: Ali, Mehreen, et al.
Publicado: (2018)

Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression
por: Ammad-ud-din, Muhammad, et al.
Publicado: (2017)

Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer
por: Wang, Tianduanyi, et al.
Publicado: (2020)

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions
por: Tang, Jing, et al.
Publicado: (2018)

Multiobjective optimization identifies cancer-selective combination therapies
por: Pulkkinen, Otto I., et al.
Publicado: (2020)

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
por: Malani, Disha, et al.
Publicado: (2022)

SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Novel Screening Method Identifies PI3Kα, mTOR, and IGF1R as Key Kinases Regulating Cardiomyocyte Survival
por: Elmadani, Manar, et al.
Publicado: (2019)

Measuring Zak phase in room-temperature atoms
por: Mao, Ruosong, et al.
Publicado: (2022)

Direct extraction of topological Zak phase with the synthetic dimension
por: Li, Guangzhen, et al.
Publicado: (2023)

Topics in the geometry of projective space: recent work of FL Zak
por: Lazarsfeld, R, et al.
Publicado: (1984)

Computational and Functional Analysis of Structural Features in the ZAKα Kinase
por: Johansen, Valdemar Brimnes Ingemann, et al.
Publicado: (2023)

Toward more realistic drug–target interaction predictions
por: Pahikkala, Tapio, et al.
Publicado: (2015)

Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
por: He, Liye, et al.
Publicado: (2021)

A Requirement for ZAK Kinase Activity in Canonical TGF-β Signaling()
por: Nyati, Shyam, et al.
Publicado: (2016)

Long-range ballistic transport of Brown-Zak fermions in graphene superlattices
por: Barrier, Julien, et al.
Publicado: (2020)

Orthogonal Time Frequency Space Modulation Based on the Discrete Zak Transform
por: Lampel, Franz, et al.
Publicado: (2022)

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects
por: Julkunen, Heli, et al.
Publicado: (2020)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin
por: Wong, John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_he4r07vmn94e135peukuvfgufm